Press coverage about Tabula Rasa Healthcare (NASDAQ:TRHC) has trended somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Tabula Rasa Healthcare earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 44.7308537233481 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Several equities analysts have recently commented on the stock. Chardan Capital assumed coverage on shares of Tabula Rasa Healthcare in a research note on Monday, July 10th. They set a “buy” rating and a $19.50 price objective for the company. Wells Fargo & Company downgraded shares of Tabula Rasa Healthcare from an “outperform” rating to a “market perform” rating and upped their price objective for the company from $17.00 to $21.00 in a research note on Thursday, September 7th. Zacks Investment Research raised shares of Tabula Rasa Healthcare from a “hold” rating to a “strong-buy” rating and set a $31.00 price objective for the company in a research note on Wednesday, October 11th. Robert W. Baird reaffirmed an “outperform” rating and set a $30.00 price objective (up from $22.00) on shares of Tabula Rasa Healthcare in a research note on Tuesday, October 17th. Finally, Piper Jaffray Companies reaffirmed an “overweight” rating and set a $20.00 price objective (up from $19.00) on shares of Tabula Rasa Healthcare in a research note on Wednesday, August 9th. Two equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. Tabula Rasa Healthcare has an average rating of “Buy” and a consensus target price of $25.57.
Tabula Rasa Healthcare (NASDAQ:TRHC) traded up 0.08% during trading on Monday, reaching $26.39. 42,038 shares of the company were exchanged. The company’s 50-day moving average price is $26.19 and its 200-day moving average price is $26.19. Tabula Rasa Healthcare has a 1-year low of $10.39 and a 1-year high of $28.53. The stock’s market capitalization is $456.18 million.
Tabula Rasa Healthcare (NASDAQ:TRHC) last announced its quarterly earnings data on Monday, August 7th. The company reported $0.06 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.06. Tabula Rasa Healthcare had a negative net margin of 10.27% and a negative return on equity of 9.58%. The company had revenue of $29.70 million during the quarter, compared to analyst estimates of $27.84 million. The business’s revenue was up 32.6% compared to the same quarter last year. On average, equities analysts forecast that Tabula Rasa Healthcare will post $0.39 EPS for the current year.
In related news, insider Orsula V. Knowlton sold 8,000 shares of Tabula Rasa Healthcare stock in a transaction dated Wednesday, September 13th. The shares were sold at an average price of $22.10, for a total transaction of $176,800.00. Following the completion of the sale, the insider now owns 887,407 shares in the company, valued at approximately $19,611,694.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders have sold a total of 24,000 shares of company stock valued at $527,920 in the last quarter. 45.80% of the stock is currently owned by company insiders.
ILLEGAL ACTIVITY NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect Tabula Rasa Healthcare (TRHC) Share Price” was first published by Community Financial News and is the sole property of of Community Financial News. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://www.com-unik.info/2017/10/30/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-tabula-rasa-healthcare-trhc-share-price.html.
Tabula Rasa Healthcare Company Profile
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
What are top analysts saying about Tabula Rasa Healthcare Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Tabula Rasa Healthcare Inc. and related companies.